Congratulations to the MSB team and a special mention to Angioblast, Hanson Insitute in SA and our CEO Silviu Itescu
for their efforts in progressing this life saving regenaritive medicine.
Looking at the Cephalon Website they have an earnings call on 10 Feb 2011(the day following the EGM).
Following Cephalons earnings call,IMO there should be US Analyst coverage on MSB (as one of there own has now invested in this intriging Aussie Biotech)and this together with ASX200 potential entrance status will only further add to the interest of fund managers and the like.
The above are only my views so please DYOR.
all time high reached - congratulation msb, page-8
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
0.035(3.21%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.09 | $1.13 | $1.07 | $3.910M | 3.535M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 27197 | $1.11 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 43578 | 3 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |